USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,788 Shares
USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 28,788 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $57.19, for a total value of $1,646,385.72. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Shares of USANA Health Sciences, Inc. (USNA) traded down 0.61% during trading on Friday, hitting $57.00. The stock had a trading volume of 185,419 shares. The company has a market capitalization of $1.39 billion, a P/E ratio of 14.81 and a beta of 1.10. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $75.00. The firm has a 50-day moving average of $57.59 and a 200 day moving average of $60.18.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, July 25th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.06 by ($0.08). The business had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The company’s revenue was down .5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.07 earnings per share. Equities research analysts predict that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.
USANA Health Sciences announced that its Board of Directors has initiated a share buyback program on Tuesday, July 25th that permits the company to repurchase $64.60 million in shares. This repurchase authorization permits the company to purchase up to 46% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its stock is undervalued.
A number of hedge funds have recently modified their holdings of USNA. Janney Montgomery Scott LLC grew its position in USANA Health Sciences by 37.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 6,619 shares of the company’s stock worth $381,000 after purchasing an additional 1,813 shares in the last quarter. Russell Investments Group Ltd. grew its position in USANA Health Sciences by 11.8% in the 1st quarter. Russell Investments Group Ltd. now owns 27,619 shares of the company’s stock worth $1,591,000 after purchasing an additional 2,926 shares in the last quarter. Wells Fargo & Company MN grew its position in USANA Health Sciences by 70.8% in the 1st quarter. Wells Fargo & Company MN now owns 31,480 shares of the company’s stock worth $1,814,000 after purchasing an additional 13,044 shares in the last quarter. First Trust Advisors LP grew its position in USANA Health Sciences by 104.3% in the 1st quarter. First Trust Advisors LP now owns 25,069 shares of the company’s stock worth $1,444,000 after purchasing an additional 12,800 shares in the last quarter. Finally, Karp Capital Management Corp bought a new stake in USANA Health Sciences in the 1st quarter worth about $595,000. 44.90% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have issued reports on the company. BidaskClub upgraded USANA Health Sciences from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. Pivotal Research lowered their target price on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a report on Wednesday, July 26th.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.